At this time, posts about Syntekabio are rapidly increasing on portals and stock communities, while foreign investors are tentatively reported to have sold a net 4,000 shares today. Syntekabio is known as a genomic big data research company.


As of 11:30 AM on the 17th, Syntekabio's stock price is 25,250 KRW, up 1.2% from the previous day, with a trading volume of 782,607 shares, which is 44.75% of the 5-day average trading volume. On September 16, Syntekabio was a market topic due to the news of developing 'drug repositioning' technology.


In addition to Syntekabio, posts by investors are also surging for Doosan Heavy Industries & Construction (034020), UbioLogics (206650), and LG Chem Preferred (051915).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing